{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:34:49Z","timestamp":1790703289882,"version":"4.1.0"},"reference-count":48,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"645","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2022,5,18]]},"abstract":"<jats:p>The rapid spread of the highly contagious Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene has raised alarms about the effectiveness of current medical countermeasures. To address this concern, we measured the neutralization of the Omicron BA.1 variant pseudovirus by postvaccination serum samples after two and three immunizations with the Pfizer\/BioNTech162b2 SARS-CoV-2 mRNA (Pfizer\/BNT162b2) vaccine, convalescent serum samples from unvaccinated individuals infected by different variants, and clinical-stage therapeutic antibodies. We found that titers against the Omicron variant were low or undetectable after two immunizations and in many convalescent serum samples, regardless of the infecting variant. A booster vaccination increased titers more than 30-fold against Omicron to values comparable to those seen against the D614G variant after two immunizations. Neither age nor sex was associated with the differences in postvaccination antibody responses. We also evaluated 18 clinical-stage therapeutic antibody products and an antibody mimetic protein product obtained directly from the manufacturers. Five monoclonal antibodies, the antibody mimetic protein, three antibody cocktails, and two polyclonal antibody preparations retained measurable neutralization activity against Omicron with a varying degree of potency. Of these, only three retained potencies comparable to the D614G variant. Two therapeutic antibody cocktails in the tested panel that are authorized for emergency use in the United States did not neutralize Omicron. These findings underscore the potential benefit of mRNA vaccine boosters for protection against Omicron and the need for rapid development of antibody therapeutics that maintain potency against emerging variants.<\/jats:p>","DOI":"10.1126\/scitranslmed.abn8543","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:58:01Z","timestamp":1649152681000},"source":"Crossref","is-referenced-by-count":90,"title":["SARS-CoV-2 BA.1 variant is neutralized by vaccine booster\u2013elicited serum but evades most convalescent serum and therapeutic antibodies"],"prefix":"10.1126","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-0450","authenticated-orcid":true,"given":"Sabrina","family":"Lusvarghi","sequence":"first","affiliation":[{"name":"Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Pollett","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-1929","authenticated-orcid":true,"given":"Sabari Nath","family":"Neerukonda","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2935-6388","authenticated-orcid":true,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-3161","authenticated-orcid":true,"given":"Richard","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2295-5890","authenticated-orcid":true,"given":"Russell","family":"Vassell","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5363-075X","authenticated-orcid":true,"given":"Nusrat J.","family":"Epsi","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-1353","authenticated-orcid":true,"given":"Anthony C.","family":"Fries","sequence":"additional","affiliation":[{"name":"U.S. Air Force School of Aerospace Medicine, Wright-Patterson Air Force Base, Fairborn, OH 45433, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5114-1669","authenticated-orcid":true,"given":"Brian K.","family":"Agan","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-7404","authenticated-orcid":true,"given":"David A.","family":"Lindholm","sequence":"additional","affiliation":[{"name":"Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, San Antonio, TX 78234, USA."},{"name":"Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5499-3368","authenticated-orcid":true,"given":"Christopher J.","family":"Colombo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."},{"name":"Madigan Army Medical Center, Joint Base Lewis McChord, Tacoma, WA 98431, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3862-4495","authenticated-orcid":true,"given":"Rupal","family":"Mody","sequence":"additional","affiliation":[{"name":"William Beaumont Army Medical Center, El Paso, TX 799218, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-9973","authenticated-orcid":true,"given":"Evan C.","family":"Ewers","sequence":"additional","affiliation":[{"name":"Fort Belvoir Community Hospital, Fort Belvoir, Fairfax county, VA 22060, USA, 22060."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahaniyat","family":"Lalani","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."},{"name":"Naval Medical Center Portsmouth, Portsmouth, VA 23708, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Ganesan","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."},{"name":"Walter Reed National Military Medical Center, Bethesda, MD 20889, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6284-4346","authenticated-orcid":true,"given":"Emilie","family":"Goguet","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."},{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-9772","authenticated-orcid":true,"given":"Monique","family":"Hollis-Perry","sequence":"additional","affiliation":[{"name":"Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, MD 20910, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u2019Ana A.","family":"Coggins","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA."},{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Simons","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-6758","authenticated-orcid":true,"given":"Leah C.","family":"Katzelnick","sequence":"additional","affiliation":[{"name":"Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3454-7392","authenticated-orcid":true,"given":"Gregory","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, MD 20910, USA."},{"name":"General Dynamics Information Technology, Falls Church, VA 22042, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3077-9505","authenticated-orcid":true,"given":"David R.","family":"Tribble","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bentley","sequence":"additional","affiliation":[{"name":"Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Human Health and Services, Washington, D.C. 20201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Eakin","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, MD 20892, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5382-0510","authenticated-orcid":true,"given":"Christopher C.","family":"Broder","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-4391","authenticated-orcid":true,"given":"Karl J.","family":"Erlandson","sequence":"additional","affiliation":[{"name":"Influenza and Emerging Infectious Diseases Division, Biomedical Advanced Research and Development Authority, U.S. Department of Health and Human Services, Washington, D.C. 20024, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-2584","authenticated-orcid":true,"given":"Eric D.","family":"Laing","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-8370","authenticated-orcid":true,"given":"Timothy H.","family":"Burgess","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-3266","authenticated-orcid":true,"given":"Edward","family":"Mitre","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-1289","authenticated-orcid":true,"given":"Carol D.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.07.027"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01676-0"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04389-z"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04388-0"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.033"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119451"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119912"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.046"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04399-5"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"K. Basile R. J. Rockett K. McPhie M. Fennell J. Johnson-Mackinnon J. E. Agius W. Fong H. Rahman D. Ko L. Donavan L. Hueston C. Lam A. Arnott S. C. A. Chen S. Maddocks M. V. O\u2019Sullivan D. E. Dwyer V. Sintchenko J. Kok Improved neutralization of the SARS-CoV-2 omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting. bioRxiv 2021.2012.2012.472252 (2021).","DOI":"10.1101\/2021.12.12.472252"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn7760"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.032"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","unstructured":"N. Ikemura A. Hoshino Y. Higuchi S. Taminishi T. Inaba S. Matoba SARS-CoV-2 Omicron variant escapes neutralization by vaccinated and convalescent sera and therapeutic monoclonal antibodies. medRxiv 2021.2012.2013.21267761 (2021).","DOI":"10.1101\/2021.12.13.21267761"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04386-2"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119358"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119641"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119236"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"A. Wilhelm M. Widera K. Grikscheit T. Toptan B. Schenk C. Pallas M. Metzler N. Kohmer S. Hoehl F. A. Helfritz T. Wolf U. Goetsch S. Ciesek Reduced neutralization of SARS-COV-2 omicron variant by vaccine sera and monoclonal antibodies. medRxiv 2021.2012.2007.21267432. 8 December 2021. https:\/\/doi.org\/10.1101\/2021.12.07.21267432.","DOI":"10.1101\/2021.12.07.21267432"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1041"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04387-1"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04385-3"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01678-y"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06233-1"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2804.212037"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","unstructured":"E. D. Laing S. L. Sterling S. A. Richard N. J. Epsi S. Coggins E. C. Samuels S. Phogat L. Yan N. Moreno C. L. Coles M. Drew J. Mehalko S. Merritt K. Mende V. Munster E. de Wit K. K. Chung E. V. Millar D. R. Tribble M. P. Simons S. D. Pollett D. Esposito C. Lanteri G. T. Clifton E. Mitre T. H. Burgess C. C. Broder Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses. medRxiv 10.1101\/2021.02.10.21251518. 12 February 2021. https:\/\/doi.org\/10.1101\/2021.02.10.21251518.","DOI":"10.1101\/2021.02.10.21251518"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab556"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01110-21"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.06.003"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","unstructured":"K. Westendorf L. Wang S. Zentelis D. Foster P. Vaillancourt M. Wiggin E. Lovett R. van der Lee J. Hendle A. Pustilnik J. M. Sauder L. Kraft Y. Hwang R. W. Siegel J. Chen B. A. Heinz R. E. Higgs N. Kallewaard K. Jepson R. Goya M. A. Smith D. W. Collins D. Pellacani P. Xiang V. de Puyraimond M. Ricicova L. Devorkin C. Pritchard A. O\u2019Neill K. Dalal P. Panwar H. Dhupar F. A. Garces C. Cohen J. Dye K. E. Huie C. V. Badger D. Kobasa J. Audet J. J. Freitas S. Hassanali I. Hughes L. Munoz H. C. Palma B. Ramamurthy R. W. Cross T. W. Geisbert V. Menacherry K. Lokugamage V. Borisevich I. Lanz L. Anderson P. Sipahimalani K. S. Corbett E. S. Yang Y. Zhang W. Shi T. Zhou M. Choe J. Misasi P. D. Kwong N. J. Sullivan B. S. Graham T. L. Fernandez C. L. Hansen E. Falconer J. R. Mascola B. E. Jones B. C. Barnhart LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. bioRxiv 10.1101\/2021.04.30.442182. 24 March 2022. https:\/\/doi.org\/10.1101\/2021.04.30.442182.","DOI":"10.1016\/j.celrep.2022.110812"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","unstructured":"S. Rothenberger D. L. Hurdiss M. Walser F. Malvezzi J. Mayor S. Ryter H. Moreno N. Liechti A. Bosshart C. Iss V. Calabro A. Cornelius T. Hospodarsch A. Neculcea T. Looser A. Schlegel S. Fontaine D. Villemagne M. Paladino Y. Kaufmann D. Schaible I. Schlegel D. Schiegg C. Zitt G. Sigrist M. Straumann F. Sacarcelik J. Wolter M. Comby J. M. Adler K. Eschke M. Nascimento A. Abdelgawad A. D. Gruber J. Bushe O. Kershaw H. Lyoo C. Wang W. Li I. Drulyte W. Du H. K. Binz R. Herrup S. Lusvarghi S. N. Neerukonda R. Vassell W. Wang S. Mangold C. Reichen F. Radom C. G. Knutson K. K. Balavenkatraman K. Ramanathan S. Lewis R. Watson M. A. Haeuptle A. Z\u00fcrcher K. M. Dawson D. Steiner C. D. Weiss P. Amstutz F. J. M. van Kuppeveld M. T. Stumpp B.-J. Bosch O. Engler J. Trimpert Ensovibep a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants. bioRxiv 2021.2002.2003.429164. 26 February 2022. https:\/\/doi.org\/10.1101\/2021.02.03.429164.","DOI":"10.1101\/2021.02.03.429164"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13081498"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2548-6"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4830"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102685"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2456-9"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl8124"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0831"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16378"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115926"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","article-title":"Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance - VISION Network, 10 States, August 2021\u2013January 2022","volume":"71","author":"Thompson M. G.","year":"2022","unstructured":"M. G. Thompson, K. Natarajan, S. A. Irving, E. A. Rowley, E. P. Griggs, M. Gaglani, N. P. Klein, S. J. Grannis, M. B. DeSilva, E. Stenehjem, S. E. Reese, M. Dickerson, A. L. Naleway, J. Han, D. Konatham, C. McEvoy, S. Rao, B. E. Dixon, K. Dascomb, N. Lewis, M. E. Levy, P. Patel, I. C. Liao, A. B. Kharbanda, M. A. Barron, W. F. Fadel, N. Grisel, K. Goddard, D. H. Yang, M. H. Wondimu, K. Murthy, N. R. Valvi, J. Arndorfer, B. Fireman, M. M. Dunne, P. Embi, E. Azziz-Baumgartner, O. Zerbo, C. H. Bozio, S. Reynolds, J. Ferdinands, J. Williams, R. Link-Gelles, S. J. Schrag, J. R. Verani, S. Ball, T. C. Ong, Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance - VISION Network, 10 States, August 2021\u2013January 2022. MMWR Morb Mortal Wkly Rep. 71, 139\u2013145 (2022).","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.026"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.07.008"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","unstructured":"T. Zhou L. Wang J. Misasi A. Pegu Y. Zhang D. R. Harris A. S. Olia C. A. Talana E. S. Yang M. Chen M. Choe W. Shi I. T. Teng A. Creanga C. Jenkins K. Leung T. Liu E.-S. D. Stancofski T. Stephens B. Zhang Y. Tsybovsky B. S. Graham J. R. Mascola N. J. Sullivan P. D. Kwong Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. bioRxiv 2021.2012.2027.474307. 28 December 2021. https:\/\/doi.org\/10.1101\/2021.12.27.474307.","DOI":"10.1101\/2021.12.27.474307"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi6226"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn8652"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248348"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.abn8543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T13:13:56Z","timestamp":1705410836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abn8543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":48,"journal-issue":{"issue":"645","published-print":{"date-parts":[[2022,5,18]]}},"alternative-id":["10.1126\/scitranslmed.abn8543"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.abn8543","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.22.473880","asserted-by":"object"}]},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"article-number":"eabn8543"}}